ExxonMobil expands healthcare portfolio

ExxonMobil, an international energy company, has expanded its portfolio of healthcare solutions. The portfolio consists of a wide range of high-performance products that are produced using Good Manufacturing Practices. 

Gertrud Masure, EMEAF market development manager Polypropylene, Vistamaxx and Exact, ExxonMobil, said: “ExxonMobil has a long history of product development in the medical industry ― about 100 years with multiple products introduced during that time. We want to be an international collaborative player in the healthcare sector.   

“That's really what this launch is about. It's putting products together that were already present in the market and demonstrating that we are a serious player, an intentional player, a global player, and collaborating to find solutions together with the industry.” 

The portfolio is said to maximise performance and longevity for a range of medical supplies, deliver high-purity products for laboratory components and pharmaceutical packaging, as well as enhance cleanliness for better infection protection. It will include Achieve Advanced PP, ExxonMobil PP, Vistamaxx performance polymers, Exact plastomers, Exxon butyl rubbers, Exxpro specialty elastomers and ExxonMobil Isopropyl Alcohol (IPA). 

Customers are looking for single-source materials, that offer opportunities for more sustainable solutions. For example, ExxonMobil has developed polyvinyl chloride (PVC) alternatives. 

“There's been some changes in the market with a move away from using PVC. The process for changing material can be a long process depending on the customer's need and being able to get certified. But we do have alternatives in that space that are polyolefin based,” Masure explains. 

Abigail Agentis, Americas market developer Polypropylene, Vistamaxx and Exact adds, “Our Vistamaxx performance polymers combined with some of our polypropylene products are suitable replacements for IV bag films where the desire to replace PVC exists. How we've seen this work so far in our successful collaboration cases has just been really working jointly with our customers to understand their need so that we can enable and accelerate their process of transition away from the materials that they're looking to replace and utilising these new materials that we're bringing to market with this expanded portfolio.” 

After working to master many industries, ExxonMobil wants to put their mark on the medical sector. Masure also shares their hopes in growing the company in the healthcare industry. 

“We have been present in this market for many years and we want the industry to understand that we really want to play a role as a portfolio provider. We can be that first talking point to help the customer understand what we can offer then take it from there. We do that with patient safety and sustainability in mind. 

“We intend to do this for the long term. We want to be a player for the next hundred years, and this is a very serious commitment. Long-term supply reliability is very crucial to the medical industry and that's what we're committed to.”